GGrantIndex
← Search

NONINVASIVE DETECTION OF AR-FL/AR-V7 AS A PREDICTIVE BIOMARKER FOR THERAPEUTIC RESISTANCE IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

$600,000FY2015Department of DefenseDOD

Institute Of Cancer Research: Royal Cancer Hospital (The)

Investigators

View source on USAspending →
NONINVASIVE DETECTION OF AR-FL/AR-V7 AS A PREDICTIVE BIOMARKER FOR THERAPEUTIC RESISTANCE IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER · GrantIndex